1 citations · 1 across the 1 of their papers we have counts for
1 paper
Shengjie Xu, Lingxi Xie
Antibody-drug conjugates (ADCs) have emerged as a promising class of targeted cancer therapeutics, but the design and optimization of their cytotoxic payloads remain challenging. T…